Trending Stories

Insights and updates

European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion’s plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism USA – English Italia – Italiano

[ad_1] This designation marks a significant milestone for patients and reaffirms Kedrion’s commitment to addressing unmet medical needs in rare and ultra-rare diseases CASTELVECCHIO PASCOLI, Italy, Nov. 27, 2025 /PRNewswire/ — Kedrion announces that the European […]